Galectin Therapeutics Reports Q3 2019 Financial Results

Go back to Galectin Therapeutics Reports Q3 2019 Financial Results
GALECTIN (NASDAQ: GALT) Delayed: 3.71 +0.19 (5.40%)
Previous Close $3.52    52 Week High $3.05 
Open $3.54    52 Week Low $0.49 
Day High $3.77    P/E N/A 
Day Low $3.54    EPS $-1.32 
Volume 121,512